Former Allergan CEO talks about the importance of affordability in healthcare

Vesper healthcare acquisition made its market debut on Sept. 30. Launched by former Allergan CEO Brent Saunders, he joins 'Closing Bell' to talk about the state of the healthcare industry and his reasons for taking his company public via SPAC. The interest was quite robust, he says, but the real work is ahead of us now that the IPO is behind us. The goal of Vesper is build a company that's a leader in health care, including aesthetic medicine, ophthalmology and health and wellness, he adds.